Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Shandong Boan Biotechnology Co's
Operating Income
for the
six
months ended in Dec. 2025 was €-0.06 Mil. Shandong Boan Biotechnology Co's Interest Expense for the
six
months ended in Dec. 2025 was €-2.32 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Shandong Boan Biotechnology Co's Interest Coverage or its related term are showing as below:
FRA:UJ9'
s Interest Coverage Range Over the Past 10 Years
Min: 1.04 Med: 2.13 Max: 3.2
Current: 1.04
FRA:UJ9's Interest Coverage is ranked worse than 96.29% of 377
companies
in the Biotechnology industry
Industry Median: 106.07
vs FRA:UJ9: 1.04
Shandong Boan Biotechnology Co (FRA:UJ9) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Shandong Boan Biotechnology Co Interest Coverage Related Terms
Shandong Boan Biotechnology Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Shandong Boan Biotechnology Co Interest Coverage Chart
FRA:UJ9 vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, Shandong Boan Biotechnology Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Boan Biotechnology Co Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shandong Boan Biotechnology Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Shandong Boan Biotechnology Co's Interest Coverage falls into.
Shandong Boan Biotechnology Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Shandong Boan Biotechnology Co did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Shandong Boan Biotechnology Co (FRA:UJ9) has a Interest Coverage of 0 (At Loss) as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shandong Boan Biotechnology Co and its competitors. Over the past decade, Shandong Boan Biotechnology Co's Interest Coverage has ranged from 1.04 to 3.20. According to the industry distribution chart, Shandong Boan Biotechnology Co ranks #363 out of 377 companies in the Biotechnology industry, placing it in the top 96.3%.
Is Shandong Boan Biotechnology Co's Interest Coverage too high?
Shandong Boan Biotechnology Co's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 1.04 to a high of 3.20. Based on the distribution chart, Shandong Boan Biotechnology Co ranks #363 out of 377 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Shandong Boan Biotechnology Co has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Boan Biotechnology Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shandong Boan Biotechnology Co ranks #363 out of 377 companies for Interest Coverage. This places Shandong Boan Biotechnology Co in the lower half of its industry. The industry median Interest Coverage is 106.07. Historically, Shandong Boan Biotechnology Co's own Interest Coverage has ranged from 1.04 to 3.20 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shandong Boan Biotechnology Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Boan Biotechnology Co's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Boan Biotechnology Co stock overvalued right now?
Shandong Boan Biotechnology Co (FRA:UJ9) has a current Interest Coverage of 0 (At Loss). The stock's GF Value™ is €1.69, compared to a current price of €0.52 — trading 69.2% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Shandong Boan Biotechnology Co's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Shandong Boan Biotechnology Co (FRA:UJ9), the current Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Boan Biotechnology Co (FRA:UJ9) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Boan Biotechnology Co stock appears to be undervalued.
The current stock price of €0.52 is trading 69.2% below its estimated GF Value™ of €1.69.
Key valuation signals for FRA:UJ9:
Interest Coverage: 0 (At Loss)
GF Value™: €1.69 vs. price of €0.52 (69.2% below fair value)
No single metric tells the full story. See the FRA:UJ9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Boan Biotechnology Co Business Description
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. It is focused on developing, manufacturing, and marketing biologics, with a focus on oncology, autoimmune diseases, ophthalmology, and metabolic diseases. The company's drug discovery activities revolve around multiple platforms: Fully Human Antibody Platform, bsAb/msAb/Probody Platform, and ADC Platform. It has commercialized several products, such as Boyounuo, Boyoubei (denosumab injection 60 mg), Boluojia (denosumab injection 120 mg), Boyouping (dulaglutide injection), and Boyoujing; and is actively engaged in the development of other drugs like BA1104 (nivolumab injection), BA1106, BA1302 (an anti-CD228 ADC), etc. Geographically, the company generates maximum revenue from the Chinese mainland.
44GF Score
Get the complete analysis for FRA:UJ9
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:UJ9 has been successfully added to your 
